Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00162175
Other study ID # CV168-021
Secondary ID
Status Completed
Phase Phase 3
First received September 9, 2005
Last updated September 10, 2010
Start date July 2003
Est. completion date November 2005

Study information

Verified date September 2007
Source Bristol-Myers Squibb
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 in Combination with Glyburide Therapy in Subjects with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sulfonylurea Therapy Alone.


Recruitment information / eligibility

Status Completed
Enrollment 534
Est. completion date November 2005
Est. primary completion date November 2005
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Type 2 Diabetes, HbA1c > 7.0% and < 10.0%, mean serum triglyceride < 600 mg/dL, body mass index < 41 kg/m2, fasting c-peptide . 1.5 ng/mL.

Exclusion Criteria:

- History of MI (myocardial infarction), coronary angioplasty or bypass graft(s), valvular disease or repair, unstable angina pectoris, transient ischemic attack (TIA), cerebrovascular attack, or cerebrovascular accident (CVA) within 6 months, congestive heart failure (NYHA Class III and IV, uncontrolled hypertension, history or renal disease, peripheral vascular disease (PVD), pulmonary disease, gastrointestinal disease, active liver disease or endocrine disease.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Muraglitazar


Locations

Country Name City State
Argentina Local Institution Bahia Blanca Buenas Aires
Argentina Local Institution Buenos Aires
Argentina Local Institution Capital Federal Buenos Aires
Argentina Local Institution Cordoba
Argentina Local Institution Mendoza
Australia Local Institution Brisbane Queensland
Australia Local Institution Canberra New South Wales
Australia Local Institution Wollongong New South Wales
Brazil Local Institution Belem Para
Brazil Local Institution Curitiba Parana
Brazil Local Institution Marilia Sao Paulo
Brazil Local Institution Porto Alegre Rio Grande Do Sul
Canada Local Institution Corunna Ontario
Canada Local Institution Gatineau Quebec
Canada Local Institution Hawksbury Ontario
Canada Local Institution Laval Quebec
Canada Local Institution Sarnia Ontario
Canada Local Institution St. Jerome Quebec
Canada Local Institution St. John's
France Local Institution Broglie
France Local Institution Chartres
France Local Institution Gemenos
France Local Institution Husseren Wesserling
France Local Institution Labarthe Sur Leze
France Local Institution Rosiers D'Egletons
Germany Local Institution Dresden
Germany Local Institution Hamburg
Germany Local Institution Nuernberg
Germany Local Institution Viernheim Schwenningen
Italy Local Institution Ravenna
Mexico Local Institution Albuquerque New Mexico
Mexico Local Institution Durango
Mexico Local Institution Leon Guanajuato
Mexico Local Institution Merida Yucatan
Mexico Local Institution Mexico Distrito Federal
Mexico Local Institution Monterrey Nuevo Leon
Mexico Local Institution Tijuana Baja California
Netherlands Local Institution Deurne
Netherlands Local Institution Ewyk
Netherlands Local Institution Hoogvliet
Netherlands Local Institution Rijswijk
Netherlands Local Institution S Gravenhage
Netherlands Local Institution Zwijndrecht
Peru Local Institution Arequipa
Peru Local Institution Lima
Puerto Rico Local Institution Carolina
Puerto Rico Local Institution Guaynabo
Puerto Rico Local Institution Ponce
Puerto Rico Local Institution Rio Piedras
Russian Federation Local Institution Moscow
Russian Federation Local Institution Saratov
Russian Federation Local Institution Smolensk
Russian Federation Local Institution St. Petersburg
Spain Local Institution A Coruna
Spain Local Institution Alicante
Spain Local Institution Cadiz
Spain Local Institution Granada
Spain Local Institution La Coruna
Spain Local Institution Las Palmas DE
Spain Local Institution Madrid
Spain Local Institution Oviedo
Spain Local Institution Santiago de Compostela
Spain Local Institution Tenerife
Spain Local Institution Teruel
Spain Local Institution Zaragoza
United Kingdom Local Institution Aldershot Hampshire
United Kingdom Local Institution Bath Wiltshire
United Kingdom Local Institution Bexhill-on-Sea East Sussex
United Kingdom Local Institution Blackpool Lancashire
United Kingdom Local Institution Glasgow Lanarkshire
United Kingdom Local Institution Harrow Middlesex
United Kingdom Local Institution Hastings Sussex
United Kingdom Local Institution Inkberrow Worcestershire
United Kingdom Local Institution Soham Cambridgeshire
United Kingdom Local Institution Sunbury on Thames Greater London
United Kingdom Local Institution Swan Lane
United States Local Institution Altoona Pennsylvania
United States Local Institution Anderson South Carolina
United States Local Institution Anniston Alabama
United States Local Institution Arden Hills Minnesota
United States Local Institution Berkley Michigan
United States Local Institution Bluefield West Virginia
United States Local Institution Bristol Tennessee
United States Local Institution Charlotte North Carolina
United States Local Institution Chester Maryland
United States Local Institution Chicago Illinois
United States Local Institution Chipley Florida
United States Local Institution Cincinnati Ohio
United States Local Institution Colorado Springs Colorado
United States Local Institution Corvallis Oregon
United States Local Institution Cranston Rhode Island
United States Local Institution Dallas Texas
United States Local Institution Denver Colorado
United States Local Institution Detroit Michigan
United States Local Institution Duncan South Carolina
United States Local Institution Dunwoody Georgia
United States Local Institution East Syracuse New York
United States Local Institution Encinitas California
United States Local Institution Eugene Oregon
United States Local Institution Excelsior Springs Missouri
United States Local Institution Greensboro North Carolina
United States Local Institution Gulfport Mississippi
United States Local Institution Hickory North Carolina
United States Local Institution Hoover Alabama
United States Local Institution Houston Texas
United States Local Institution Huntersville North Carolina
United States Local Institution Huntsville Alabama
United States Local Institution Irving Texas
United States Local Institution Kansas City Missouri
United States Local Institution Kingsport Tennessee
United States Local Institution Knoxville Tennessee
United States Local Institution Lake Jackson Texas
United States Local Institution Lexington Kentucky
United States Local Institution Little Rock Arkansas
United States Local Institution Long Beach California
United States Local Institution Los Angeles California
United States Local Institution Loveland Colorado
United States Local Institution Marshfield Wisconsin
United States Local Institution Memphis Tennessee
United States Local Institution Mesa Arizona
United States Local Institution Miami Florida
United States Local Institution Mission Viejo California
United States Local Institution Mobile Alabama
United States Local Institution Morehead City North Carolina
United States Local Institution New Port Richey Florida
United States Local Institution Oklahoma City Oklahoma
United States Local Institution Olympia Washington
United States Local Institution Overland Park Kansas
United States Local Institution Pasadena California
United States Local Institution Philadelphia Pennsylvania
United States Local Institution Phoenix Arizona
United States Local Institution Pinellas Park Florida
United States Local Institution Portland Oregon
United States Local Institution San Antonio Texas
United States Local Institution San Diego California
United States Local Institution Silver Springs Maryland
United States Local Institution Simpsonville South Carolina
United States Local Institution Slidell Louisiana
United States Local Institution Springfield Massachusetts
United States Local Institution St. Louis Missouri
United States Local Institution Summerville South Carolina
United States Local Institution The Colony Texas
United States Local Institution Tucson Arizona
United States Local Institution Tulsa Oklahoma
United States Local Institution Vero Beach Florida
United States Local Institution Walnut Creek California
United States Local Institution Westlake Village California
United States Local Institution Wheat Ridge Colorado
United States Local Institution Wilmington North Carolina
United States Local Institution Winter Park Florida

Sponsors (1)

Lead Sponsor Collaborator
Bristol-Myers Squibb

Countries where clinical trial is conducted

United States,  Argentina,  Australia,  Brazil,  Canada,  France,  Germany,  Italy,  Mexico,  Netherlands,  Peru,  Puerto Rico,  Russian Federation,  Spain,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Compare change from baseline in HbA1c after 24 weeks of treatment with muraglitazar + glyburide vs placebo + glyburide
Secondary Change in FPG from basline to W24, proportion of subjects receiving therapeutic response at W24, percent change of fasting lipid levels from baseline to W11/12, change in hs-CRP from baseline to W24